A number of compounds alleged to inhibit histidine decarboxylase in vitro and in vivo, were tested in mice for ability to reduce histamine formation in cell types containing this enzyme. Mice were pretreated with 'inhibitor' or saline, injected with 14C-L-histidine, and after an interval suitable for each cell type, sacrificed. For mast cell histidine decarboxylase, skin was assayed; for enzyme in enteroehromaflin-like cells, stomach was assayed; for brain ceils (cell type unidentified at present) whole brain was assayed. Most tested compounds had little or no effect on histamine formation. Only one drug, 4-imidazole-3-amino-2-butanone showed strong activity in both skin and stomach samples; it did not affect brain histamine formation, possibly because it does not enter brain.